fashion -WSS

fashion

author：focus 2025-10-01 12:54:48 - browse：9

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

hotspot

WSS

The story of mRNA: From a loose idea to a tool that may help curb Covid

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Ask STAT: What do you want to know about ChatGPT in medicine?

Why drug prescriptions should include diagnoses

Anthos stroke drug appears safer than common blood thinner

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

explore

fashion

focus

Hollywood unions extend contract negotiations for actors

Why we need to separate burnout from moral injury in health care

The cancer drug shortage isn’t new — and neither are the solutions

Gain of function research would be limited under House proposal

Affirmative action in medical school literally saved lives

WATCH: Why do fingernails fall off when they're damaged?

After affirmative action ruling, medical educators look to 'holistic review'

Weight loss drug costs may need more research, senator suggests

Malaria cases in Florida and Texas: Here’s what you need to know

Why we need to separate burnout from moral injury in health care

knowledge

Donald Trump's relentless attacks on special counsel Jack Smith

The science behind Janet Jackson's pregnancy at 49